NAV
30.53(0.60%)Fund Size (CR)
₹1,308.56Expense Ratio
2.1Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
0.25%Return Since Launch
12.01%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Rajat Srivastava
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 1 October 2025 | 10039.93 | 0.40% | - | 0.77% | 643/920 |
1 Month | 8 September 2025 | 9899.02 | -1.01% | - | 0.76% | 791/916 |
3 Month | 8 July 2025 | 9969.19 | -0.31% | - | -0.02% | 367/880 |
6 Month | 8 April 2025 | 10926.46 | 9.26% | - | 15.60% | 777/860 |
1 Year | 8 October 2024 | 9755.15 | -2.45% | -2.45% | -0.41% | 418/750 |
3 Year | 7 October 2022 | 17997.47 | 79.97% | 21.59% | 19.62% | 154/494 |
5 Year | 8 October 2020 | 21619.74 | 116.20% | 16.66% | 22.56% | 320/390 |
Since Inception | 28 December 2015 | 30351.30 | 203.51% | 12.01% | 13.26% | 619/920 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 4 November 2024 | 1,20,000 | 123293.29 | 2.74% | 2.74% |
3 Year | 1 November 2022 | 3,60,000 | 480184.54 | 33.38% | 10.08% |
5 Year | 2 November 2020 | 6,00,000 | 933013.06 | 55.50% | 9.23% |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.60%
Standard Deviation
0.83%
Beta
1.05%
Sharpe Ratio
-0.02%
Treynor's Ratio
12.62%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 10.03% | 815483 | 130.01 | Equity | Pharmaceuticals |
Apollo Hospitals | 5.06% | 88528 | 65.59 | Equity | Healthcare |
Lupin | 4.88% | 330887 | 63.24 | Equity | Pharmaceuticals |
Cipla | 4.86% | 418868 | 62.97 | Equity | Pharmaceuticals |
Torrent Pharma. | 4.68% | 168394 | 60.68 | Equity | Pharmaceuticals |
Health.Global | 4.68% | 942453 | 60.63 | Equity | Healthcare |
Aster DM Health. | 4.63% | 956991 | 60.00 | Equity | Healthcare |
Alkem Lab | 4.46% | 106435 | 57.74 | Equity | Pharmaceuticals |
Max Healthcare | 3.95% | 458724 | 51.13 | Equity | Healthcare |
Divi's Lab. | 3.86% | 87918 | 50.02 | Equity | Pharmaceuticals |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Direct (G) | 389.09 | 3.31% | 25.97% | 102.66% | 47.53% | 38.00% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 389.09 | 3.31% | 25.97% | 102.66% | 47.53% | 38.00% | |
Aditya Birla SL International Equity Fund - Direct (G) | 249.75 | 3.93% | 11.42% | 36.27% | 29.67% | 19.61% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 249.75 | 3.93% | 11.42% | 36.27% | 29.67% | 19.61% | |
Nippon India Japan Equity Fund - Direct (G) | 283.56 | 0.90% | 11.53% | 27.40% | 17.55% | 19.54% |
List of Schemes under Tata Mutual Fund
News
Tata Mutual Fund announces change in fund manager under its schemes
Tata Mutual Fund has announced change in fund manager under the following schemes, With effect from 03 October 2025.Change in Fund Manager:
Scheme Name Existing Fund Managers New Fund Managers Tata ELSS Fund (formerly known as Tata ELSS Tax Saver Fund) 1. Rahul Singh
2. Sailesh Jain *Sailesh Jain Tata Flexi Cap Fund 1. Amey Sathe
2. Aditya Bagul *1. Anand Sharma
2. Aditya Bagul *Tata Focused Fund 1. Meeta Shetty
2. Hasmukh Vishariya1. Anand Sharma 2. Hasmukh Vishariya Powered by Capital Market - Live News
Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes
Tata Mutual Fund has announced 01 October 2025 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the monthly IDCW option and under the Periodic IDCW Periodic-Payout/Reinvestment) of following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Tata Aggressive Hybrid Fund ' Regular Plan & Direct Plan: 0.36 each.
Tata Equity Savings Fund ' Regular Plan & Direct Plan: 0.059 each.
Powered by Capital Market - Live News
Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes
Tata Mutual Fund has announced 03 September 2025 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the monthly IDCW option and under the Periodic IDCW Periodic-Payout/Reinvestment) of following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Tata Aggressive Hybrid Fund ' Regular Plan & Direct Plan: 0.36 each.
Tata Equity Savings Fund ' Regular Plan & Direct Plan: 0.059 each.
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
4 December 2015
Total AUM (Cr)
₹1295.83
Tata India Pharma & Healthcare Fund (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Tata Mutual Fund. Launched in 4 December 2015, this fund is managed by Rajat Srivastava. With assets under management (AUM) worth ₹1,295.83 (Cr), as of 9 October 2025, Tata India Pharma & Healthcare Fund (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 12.01% since its launch.
The current NAV of Tata India Pharma & Healthcare Fund (G) is ₹30.53, as on 9 October 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in Tata India Pharma & Healthcare Fund (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment. The fund has generated 21.59% and 16.66% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.28% in Equity, 0.19% in Debt and 1.53% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 57.45% in Pharmaceuticals & Biotech, 35.92% in Healthcare Services, 1.98% in Cash & Others, 1.83% in Insurance, 1.44% in Fertilisers & Agrochemica